Code | CSB-MP004970MO |
Abbreviation | Recombinant Mouse Cd93 protein, partial (Active) |
MSDS | |
Size | $114 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
This Mouse CD93 recombinant protein was produced in mammalian cell, where the gene sequence encoding Mouse CD93 (23-572aa) was expressed with the C-terminal 10xHis tag. The purity of this CD93 protein was greater than 95% by SDS-PAGE. The activity was validated.
CD93 (C1qRP, AA4.1) is a C-type lectin-like domain (CTLD) protein. The CD93 gene is considered to be derived from the gene duplication of the group XIV member thrombomodulin (TM), so it is classified as the XIV group in transmembrane glycoprotein.
CD93 was originally thought to be a C1q receptor that enhances phagocytosis. Subsequent studies showed that in CD93-null mice, phagocytosis of C1q by macrophages is enhanced despite defective clearance of apoptotic cells in vivo, and thus CD93 is not a receptor for C1q and regulates phagocytosis through an unknown mechanism. The function of CD93 is currently mainly considered to be involved in intercellular adhesion and clearance of apoptotic cells, and is associated with various inflammatory and immune-related diseases, including asthma.
CD93 is a transmembrane receptor that is upregulated in tumor blood vessels in many cancers. Studies have demonstrated that CD93 regulates β1 integrin signaling activation and fibronectin fibrillation during tumor angiogenesis.
A recent study comparing gene expression profiling of tumors under VEGF inhibitor treatment in vivo identified CD93 as a candidate receptor downregulated in VEGF inhibition and a potential target for mediating vascular normalization. This confirms the pro-angiogenic effect of CD93 in endothelial cells.
There are currently no reviews for this product.